Cargando…
Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro
In this study, we aimed to evaluate the anticancer effect of benzimidazole derivatives on triple-negative breast cancer (TNBC) and investigate its underlying mechanism of action. Several types of cancer and normal breast cells including MDA-MB-231, radiotherapy-resistant (RT-R) MDA-MB-231, and allog...
Autores principales: | Choi, Hoon Sik, Ko, Young Shin, Jin, Hana, Kang, Ki Mun, Ha, In Bong, Jeong, Hojin, Song, Haa-Na, Kim, Hye Jung, Jeong, Bae Kwon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433818/ https://www.ncbi.nlm.nih.gov/pubmed/34500557 http://dx.doi.org/10.3390/molecules26175118 |
Ejemplares similares
-
Mebendazole Increases Anticancer Activity of Radiotherapy in Radiotherapy-Resistant Triple-Negative Breast Cancer Cells by Enhancing Natural Killer Cell-Mediated Cytotoxicity
por: Choi, Hoon Sik, et al.
Publicado: (2022) -
Neural Functions Play Different Roles in Triple Negative Breast Cancer (TNBC) and non-TNBC
por: Tan, Renbo, et al.
Publicado: (2020) -
The fate of chemoresistance in triple negative breast cancer (TNBC)
por: O’Reilly, Elma A., et al.
Publicado: (2015) -
Chemotherapy with ceramide in TNBC
por: Legembre, Patrick, et al.
Publicado: (2015) -
GHRH-antagonists in TNBC
por: Engel, Jörg B.
Publicado: (2015)